IFNL1 and acquired polycythemia vera: As presented in Fig. 2A–C, IL-29 caused a markedly increase in the mRNA levels of IL-6, TNF-α and IL-17 in PBMCs from PV patients treated with IL-29 when compared with PBS controls.